Skip to search formSkip to main contentSkip to account menu

carboxycinnamic acid bishydroxamide

Known as: m-carboxycinnamic acid bishydroxamide, m-Carboxycinnamic Acid Bishydroxamic Acid, CBHA cpd 
A hybrid polar compound that induces terminal differentiation and/or apoptosis in various transformed cells. It is an inhibitor of histone… 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

CinnamatesHistone deacetylase inhibitor

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Epigenetic reprogramming, gene expression and in vitro development of porcine SCNT embryos are significantly improved by a histone deacetylase inhibitor—m-carboxycinnamic acid bishydroxamide (CBHA)
Insufficient epigenetic reprogramming of donor nuclei is believed to be one of the most important causes of low development… 
2013
2013
Notariado y Hacienda Pública en el reino de Navarra. El devengo de los sellos del rey (1294-1414)
El presente estudio deriva de un proyecto de investigacion financiado por el antiguo Ministerio de Educacion y Ciencia CBHA 2003… 
2006
2006
15-Hydroxyprostaglandin dehydrogenase (PGDH) is an aberrant tumor suppressor in human breast cancer.
10550 Background: Prostaglandin E2 plays a growth stimulatory role in breast cancer; and the rate-limiting enzyme in its… 
2004
2004
Identification of Epigenetically Silenced Tumor Suppressor Genes in Myeloid Disorders Leads to the Identification of α-Catenin as a Target Gene in 5q- Syndrome.
CpG islands in the 5′ regulatory regions of genes are generally protected from cytosine methylation as methylation in a promoter… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)